Co-amplification of ERBB2 and TOP2A has been reported in breast cancer cases, which has been attributed to their proximity to chromosome 17 (17q12 and 17q21.3-22, respectively) [14]. The gene discussed is ERBB2; the disease is breast carcinoma.